Free Trial

Beam Therapeutics (BEAM) SEC Filings & 10K Form

Beam Therapeutics logo
$20.24 +0.41 (+2.07%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$20.57 +0.33 (+1.63%)
As of 05/2/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Beam Therapeutics SEC Filings

DateFilerForm TypeView
04/10/2025
8:36 AM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2025
8:50 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:50 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:51 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:52 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:53 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:11 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:13 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:18 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:21 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:10 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
10:02 AM
Beam Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
03/31/2025
5:43 PM
Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
5:43 PM
Beam Therapeutics (Subject)
Bellon Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
5:43 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
5:44 PM
Beam Therapeutics (Subject)
Simon Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
4:23 PM
Beam Therapeutics (Filer)
Form 424B5
03/10/2025
4:02 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
5:10 AM
Beam Therapeutics (Filer)
Form 424B5
03/10/2025
5:13 AM
Beam Therapeutics (Subject)
Form FWP
03/10/2025
5:06 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
6:51 AM
Beam Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
6:30 AM
Beam Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:19 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:10 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:30 PM
Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
3:12 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:05 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
8:46 PM
ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
Form SCHEDULE 13G/A
01/06/2025
4:48 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:49 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
7:04 PM
Beam Therapeutics (Issuer)
Emany Sravan Kumar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:26 PM
Beam Therapeutics (Subject)
Bellon Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
6:29 PM
Beam Therapeutics (Subject)
Cavanagh Bethany J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:10 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
6:01 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

12/06/2024
6:06 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:18 AM
Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2024
6:22 AM
Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:10 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
8:56 AM
Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
11/05/2024
8:00 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
8:06 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
7:30 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:05 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:50 AM
Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:44 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
10:37 AM
Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
4:00 PM
Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
4:51 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:52 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:49 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:51 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:15 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
6:01 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
3:14 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:30 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:42 PM
Beam Therapeutics (Issuer)
Fishman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:42 PM
Beam Therapeutics (Issuer)
Walsh Kathleen E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:45 PM
Beam Therapeutics (Issuer)
COOPER GRAHAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:47 PM
Beam Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:47 PM
Beam Therapeutics (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:48 PM
Beam Therapeutics (Issuer)
Shaw Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:09 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:19 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BEAM) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners